[1]
Kiss, T., Katona, G. and Ambrus, R. 2021. Crystallization and physicochemical investigation of melevodopa hydrochloride, a commercially available antiparkinsonian active substance. Acta Pharmaceutica Hungarica. 91, 2 (Nov. 2021), 45-52. DOI:https://doi.org/10.33892/aph.2021.91.45-52.